September 5, 2018
Package inserts for Celgene’s psoriasis drug Otezla (apremilast) and the antibiotic ceftriaxone have been revised to update their side effect risks, the Ministry of Health, Labor and Welfare (MHLW) said in its drug safety bulletin released on September 4. Otezla...read more